Thomas Edward Hamilton
Independent Chair of the BoardMr. Thomas Edward Hamilton, also known as tom, serves as an Independent Director of Annaly Capital Management, Inc. since March 6, 2019 and serves as its Independent Chair of the Board since May 2025. Mr. Hamilton served as Chair of the Board at Annaly Capital Management, Inc. since November 21, 2019 until 2020. He serves as a Managing Director and Head of Mortgage Trading at Barclays Capital PLC. Mr. Hamilton served as a Strategic Advisor to the Global Head of Fixed Income, Currencies and Commodities at Barclays Capital in New York. He has served as a Director at Larimar Therapeutics, Inc. since May 28, 2020. He served as a Senior Adviser at Barclays Plc. Mr. Hamilton has served as the President, Chief Executive Officer, Director and Owner of Construction Forms, Inc from 2013 to September 2020. Prior to his current position, Mr. Hamilton spent many years in a number of leadership positions in the financial industry. Mr. Hamilton’s prior roles at Barclays include serving as the Global Head of Securitized Product Trading and Banking, in which capacity he was responsible for the build out of the Barclays’s Global Securitized Product businesses and as the Head of Municipal Trading and Investment Banking. Mr. Hamilton held various Managing Director roles at Citigroup, Inc. and Salomon Brothers, Inc. where he began his career. Mr. Hamilton served as Chairman of the Board of Larimar Therapeutics, Inc. (formerly Chondrial Therapeutics, Inc. ) 2013 until May 2020, a biotech company he started to cure a rare neurodegenerative disease called Friedreich’s Ataxia. He is also a Director of the Friedreich’s Ataxia Research Alliance. He is the co-founder of his own charitable scientific effort, the CureFA Foundation. Mr. Hamilton received a B.S. in Finance from the University of Dayton.
Positions
- Company NameAnnaly Capital Management, Inc.Stock CodeNLYPositionIndependent Chair of the BoardRelated SecuritiesColleagues
- DLDavid L. FinkelsteinCEO, Co-Chief investment Officer & Director
- TEThomas Edward HamiltonIndependent Chair of the Board
- SFSteven Francis CampbellCOO & President
- SISerena Iris WolfeChief Financial Officer
- MPMichael Paul FaniaCo-Chief Investment Officer & Head of Residential Credit
- SNSashi NairChief Technology Officer
- GAGlenn A. VotekIndependent Director
- VWVicki WilliamsIndependent Director
- KHKathy Hopinkah HannanIndependent Director
- Company NameLarimar Therapeutics, Inc.Stock CodeLRMRPositionIndependent DirectorColleagues
- CSCarole S. Ben-MaimonCEO & Director
- JTJoseph TruittIndependent Chairman of the Board
- MCMichael CelanoSecretary & CFO
- GSGopi ShankarChief Development Officer
- JBJohn B. HarlowPresident & COO
- JBJohn BermanVice President of Finance & Administration
- JSJonathan S. LeffIndependent Director
- FEFrank Edward ThomasIndependent Director
